Dallah Healthcare CoSAU:4004 92 Net Margin % is 8.34% as of Mar. 2026, which is 32% below its 10-year median of 12.26. GuruFocus rates SAU:4004 with a GF Score™ of 92/100 and a GF Value™ of ﷼204.73 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 665 Healthcare Providers & Services companies, Dallah Healthcare Co ranks better than 80.3% on this metric.
The historical rank and industry rank for Dallah Healthcare Co's Net Margin % or its related term are showing as below:
SAU:4004'
s Net Margin % Range Over the Past 10 Years
Min: 10.01 Med: 12.26 Max: 24.34
Current: 11
SAU:4004's Net Margin % is ranked better than 80.3% of 665
companies
in the Healthcare Providers & Services industry
Industry Median: 2.89
vs SAU:4004: 11.00
Dallah Healthcare Co (SAU:4004) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Dallah Healthcare Co Net Margin % Related Terms
Dallah Healthcare Co Net Margin % Historical Data
* Premium members only.
The historical data trend for Dallah Healthcare Co's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SAU:4004 vs HCA, THC, DVA: Net Margin % Comparison
For the Medical Care Facilities subindustry, Dallah Healthcare Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dallah Healthcare Co Net Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dallah Healthcare Co's Net Margin % distribution charts can be found below:
* The bar in red indicates where Dallah Healthcare Co's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dallah Healthcare Co (SAU:4004) has a Net Margin % of 8.34% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Dallah Healthcare Co and its competitors. This is 32% below median its historical median of 12.26. Over the past decade, Dallah Healthcare Co's Net Margin % has ranged from 10.01 to 24.34. According to the industry distribution chart, Dallah Healthcare Co ranks #131 out of 665 companies in the Healthcare Providers & Services industry, placing it in the top 19.7%.
Is Dallah Healthcare Co's Net Margin % too high?
Dallah Healthcare Co's current Net Margin % of 8.34% is 32% below median its 10-year median of 12.26. Over the past 10 years, this metric has ranged from a low of 10.01 to a high of 24.34. The Healthcare Providers & Services industry median Net Margin % is 2.89. Dallah Healthcare Co's value of 8.34% is 188.6% above this industry median. Based on the distribution chart, Dallah Healthcare Co ranks #131 out of 665 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Dallah Healthcare Co has a GF Score™ of 92/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Dallah Healthcare Co's Net Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Dallah Healthcare Co ranks #131 out of 665 companies for Net Margin %. This places Dallah Healthcare Co in the top 20% of its industry — outperforming the majority of peers. The industry median Net Margin % is 2.89. Dallah Healthcare Co's value of 8.34% is 188.6% above this benchmark. Historically, Dallah Healthcare Co's own Net Margin % has ranged from 10.01 to 24.34 over the past decade. While the company's 10-year median is 12.26 vs. the industry median of 2.89, Dallah Healthcare Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Healthcare Providers & Services company?
The median Net Margin % among Healthcare Providers & Services companies is 2.89, based on 665 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dallah Healthcare Co's current Net Margin % of 8.34% is 188.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Dallah Healthcare Co and its competitors. For the Healthcare Providers & Services industry, the median Net Margin % is 2.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dallah Healthcare Co's current Net Margin % is 8.34%, which is 32% below median its own 10-year median of 12.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dallah Healthcare Co stock overvalued right now?
Based on GuruFocus' analysis, Dallah Healthcare Co (SAU:4004) is currently considered Possible Value Trap. The stock's GF Value™ is ﷼204.73, compared to a current price of ﷼112.00 — trading 45.3% below its estimated fair value. The current Net Margin % is 8.34%, which is 32% below median its 10-year median of 12.26 and 188.6% above the Healthcare Providers & Services industry median of 2.89. Dallah Healthcare Co's overall GF Score™ is 92/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Dallah Healthcare Co (SAU:4004), the current Net Margin % is 8.34% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dallah Healthcare Co (SAU:4004) Overvalued in 2026?
Based on GuruFocus' analysis, Dallah Healthcare Co stock appears to be undervalued.
The current stock price of ﷼112.00 is trading 45.3% below its estimated GF Value™ of ﷼204.73.
GuruFocus considers Dallah Healthcare Co to be Possible Value Trap.
Key valuation signals for SAU:4004:
Net Margin %: 8.34% (32% below median its 10-year median of 12.26)
GF Value™: ﷼204.73 vs. price of ﷼112.00 (45.3% below fair value)
Industry Position: 188.6% above the Healthcare Providers & Services median (#131 of 665)
No single metric tells the full story. See the SAU:4004 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dallah Healthcare Co provides and operates healthcare programs and utilities in the Kingdom of Saudi Arabia. The objectives of the company include operating, managing, and maintaining the healthcare entities, wholesale medicines, and retail of medical and surgical equipment, prosthetics, and devices for the disabled, hospital equipment, and manufacturing medicines, pharmaceuticals, herbals, health, cosmetics, detergents, disinfectants, and packaging in the Kingdom of Saudi Arabia. The reportable segments of the company are Medical Facilities and Pharmacies, and Distribution of Pharmaceutical Products. The company generates the majority of its revenue from the Medical Facilities and Pharmacies segment.
92GF Score
Get the complete analysis for SAU:4004
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4004 has been successfully added to your 
